Ultrasound Could Spot Placenta Issues Tied to Low Birth Weight
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
TUESDAY, Feb. 6, 2024 -- Using ultrasound to measure blood flow in the placenta and the fetus could help spot issues tied to low birth weight, researchers report.
As the Dutch investigators explained, about 10% of fetuses are determined to be "small for gestational age" after ultrasound examination in the womb.
Some underweight newborns do just fine, but others may have a malfunctioning placenta, and that could place them in danger. Often, birth must be induced.
"This means it is incredibly important to track down which babies are smaller due to the placenta," said study lead author Wessel Ganzevoort, an associate professor of obstetrics at Amsterdam UMC.
Of course, ultrasound has long been used to track fetal growth.
However, the new research used "Doppler ultrasound" to look more closely at the resistance of blood vessels within the umbilical cord. According to the researchers, that can give doctors vital clues about the placental health.
The ultrasound also looks at blood flow in the fetal brain. If the blood supply is too high, that could also signal a malfunctioning placenta.
As the researchers explained it, an underperforming placenta can lead to a lack of oxygen to the fetus and other dangers.
Using Doppler ultrasound can help doctors determine if an undersized fetus requires closer monitoring or not, Ganzevoort's team said.
"By adding this Doppler ultrasound to the care plan of these undersized babies, the higher risk of problems surrounding childbirth can be better detected and monitored," he said in a medical center news release. "Small babies for whom the measurement is normal can also be monitored less intensively. There is therefore a greater chance that the delivery will take place naturally, without intervention."
As part of the study, the Dutch team also wanted to see if inducing labor before 37 weeks of labor might improve outcomes for babies thought to be threatened by a malfunctioning placenta.
The team found that early induction did not, in fact, boost outcomes. So, they now believe that it may be healthiest to let a baby benefit from staying in the womb longer.
The research was published Feb. 5 in the British Journal of Obstetrics & Gynaecology.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-06 22:15
Read more
- FDA Approves Vyalev for Advanced Parkinson Disease
- Halloween Can Be Extra Scary for Folks With Dementia. An Expert Offers Caregiver Tips
- Report Finds Big Disparities in Americans' Well-Being by Region
- FDA Appoints New Head of Medical Devices
- Too Much Sitting Harms the Heart, Even in Folks Who Exercise
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions